The effectiveness of insulin glargine 300 U/ml among type 2 diabetes patients: analysis of a real world data

被引：0
|
作者：
Cohen, C. Melzer [1 ]
Shalev, V. [1 ,2 ]
Chodick, G. [1 ,2 ]
机构：
[1] Maccabi Healthcare Serv, Maccabi Inst Res & Innovat, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
895
引用
收藏
页码：S436 / S437
页数：2
相关论文
共 50 条
  • [21] Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
    Lau, Ip Tim
    Lee, Ka Fai
    So, Wing Yee
    Tan, Kathryn
    Yeung, Vincent Tok Fai
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2017, 10 : 273 - 284
  • [22] Comparative Effectiveness of Insulin Glargine 300 U/mL (Gla-300) and Insulin Degludec 100 U/mL (iDeg-100) in Insulin-Nave Type 2 Diabetes Adults: RESTORE-2 Real-World Study
    Fadini, Gian Paolo
    Buzzetti, Raffaella
    Nicolucci, Antonio
    Rossi, Maria Chiara
    Larosa, Monica
    Cucinotta, Domenico
    [J]. DIABETES, 2021, 70
  • [23] Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study
    Hassanein, Mohamed
    Buyukbese, Mehmet Akif
    Malek, Rachid
    Pilorget, Valerie
    Naqvi, Mubarak
    Berthou, Baptiste
    Shaltout, Inass
    Sahay, Rakesh Kumar
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 166
  • [24] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Kovatchev, Boris
    Meng, Zhaoling
    Cali, Anna M. G.
    Perfetti, Riccardo
    Breton, Marc D.
    [J]. DIABETES THERAPY, 2020, 11 (06) : 1293 - 1302
  • [25] REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): THE ATOS STUDY
    Galstyan, G.
    Tirosh, A.
    Vargas-Uricoechea, H.
    Mabunay, M.
    Quan, J.
    Pilorget, V.
    Cherkasov, D.
    Naqvi, M.
    Khan, N.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A23 - A23
  • [26] Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Boris Kovatchev
    Zhaoling Meng
    Anna M. G. Cali
    Riccardo Perfetti
    Marc D. Breton
    [J]. Diabetes Therapy, 2020, 11 : 1293 - 1302
  • [27] Comparative effectiveness of insulin glargine 300 U/mL and insulin degludec 100 U/mL in insulin naive type 2 diabetes adults: the Restore-2 naive cohort
    Fadini, G. P.
    Buzzetti, R.
    Larosa, M.
    Rossi, M. C.
    Nicolucci, A.
    Cucinotta, D.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 74 - 74
  • [28] New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus
    Goldman, Jennifer
    White, John R., Jr.
    [J]. ANNALS OF PHARMACOTHERAPY, 2015, 49 (10) : 1153 - 1161
  • [29] ATOS: REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES: AD-HOC ANALYSIS OF RUSSIAN POPULATION.
    Galstyan, G.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A98 - A99
  • [30] Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis
    Nakanishi, Shuhei
    Iwamoto, Masahiro
    Kamei, Shinji
    Hirukawa, Hidenori
    Shimoda, Masashi
    Tatsumi, Fuminori
    Kohara, Kenji
    Obata, Atsushi
    Kimura, Tomohiko
    Kinoshita, Tomoe
    Irie, Shintaro
    Sanada, Junpei
    Fushimi, Yoshiro
    Nishioka, Momoyo
    Mizoguchi, Akiko
    Kameyama, Miyuki
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    [J]. INTERNAL MEDICINE, 2018, 57 (10) : 1381 - 1389
12345